Gene · 1441
Papers3,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience. | Cureus | 2023 | 37885525 | PubTator, text mining | PubMed |
| Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota. | Cell Biosci | 2023 | 37875976 | PubTator, text mining | PubMed |
| Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia. | BMC Cancer | 2023 | 37875840 | PubTator, text mining | PubMed |
| Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. | Nat Commun | 2023 | 37875494 | PubTator, text mining | PubMed |
| Anti-microbial activity and immunomodulation of recombinant hepcidin 2 and NK-lysin from flounder (Paralichthys olivaceus). | Int J Biol Macromol | 2023 | 37871716 | PubTator, text mining | PubMed |
| Transcriptomic characterization of classical monocytes highlights the involvement of immuno-inflammation in bone erosion in Rheumatoid Arthritis. | Front Immunol | 2023 | 37868981 | PubTator, text mining | PubMed |
| Hematopoietic stem cells undergo a lymphoid to myeloid switch in early stages of emergency granulopoiesis. | EMBO J | 2023 | 37846891 | PubTator, text mining | PubMed |
| CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition. | Hemasphere | 2023 | 37841755 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis. | Cancers (Basel) | 2023 | 37835487 | PubTator, text mining | PubMed |
| Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. | Leukemia | 2023 | 37833543 | PubTator, text mining | PubMed |
| Regulation of ferroptosis-related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer. | Thorac Cancer | 2023 | 37830388 | PubTator, text mining | PubMed |
| Noteworthy perspectives on microglia in neuropsychiatric disorders. | J Neuroinflammation | 2023 | 37794488 | PubTator, text mining | PubMed |
| TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression. | Nat Commun | 2023 | 37794021 | PubTator, text mining | PubMed |
| Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy. | Cell Commun Signal | 2023 | 37784164 | PubTator, text mining | PubMed |
| Single-cell analysis of graft-infiltrating host cells identifies caspase-1 as a potential therapeutic target for heart transplant rejection. | Front Immunol | 2023 | 37781362 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. | J Immunother Cancer | 2023 | 37777251 | PubTator, text mining | PubMed |
| Bioinformatics analysis of copper death gene in diabetic immune infiltration. | Medicine (Baltimore) | 2023 | 37773841 | PubTator, text mining | PubMed |
| Recent advances in therapies for primary myelofibrosis. | Fac Rev | 2023 | 37771602 | PubTator, text mining | PubMed |
| Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. | Int J Mol Sci | 2023 | 37762066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1441/papers?page=14